CAS 1246817-44-6

Dabigatran-d3

Produto Controlado

CAS: 1246817-44-6

Applications Labelled Dabigatran (D100090). Nonpeptide, direct thrombin inhibitor. Antithrombotic.
References Hauel, N., et al.: J. Med. Chem., 45, 1757 (2002), Mungall, D., et al.: Curr. Opin. Invest. Drugs, 3, 095 (2002), Stangier, J., et al.: J. Clin. Pharmacol., 45, 555 (2005),

Fórmula: C₂₅₂H₃H₂₂N₇O₃

Pureza: >90%

Cor e Forma: White To Off-White

Peso molecular: 474.53

Ref: TR-D100092

Dabigatran-d3

CAS: 1246817-44-6

Dabigatran-d3 is a potent inhibitor of kinases that has shown promising anticancer activity. This analog of Dabigatran has been shown to induce apoptosis in cancer cells and inhibit tumor growth, making it a potential candidate for the treatment of cancer. Dabigatran-d3 works by inhibiting the activity of kinases, which are enzymes that play a critical role in cell signaling pathways. It has been shown to be effective against various types of cancer, including Chinese hamster ovary cells and human breast cancer cells. Additionally, Dabigatran-d3 can be detected in urine samples, making it a useful tool for monitoring drug levels during clinical trials. Overall, this kinase inhibitor shows great promise as an anticancer agent with significant potential for further development.

Fórmula: C₂₅H₂₅N₇O₃

Pureza: Min. 95%

Peso molecular: 474.5 g/mol

Ref: 3D-WZB81744